NewVale Capital
Overview
Founded in 2021, NewVale Capital is a sector-specialist pharma services growth equity firm investing in proven, revenue-generating services and enabling technology businesses serving the life sciences…
Investment Focus
- Proven revenue generation
- Established market presence
- Alignment with life science services sector
Portfolio Companies
Reach NewVale Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about NewVale Capital
What sectors does NewVale Capital invest in?
NewVale Capital invests in Technology, Healthcare and Life Sciences, and is based in Boulder, United States. NewVale Capital is listed as a private equity in the ConnectSafely investor database.
What stage does NewVale Capital invest at?
NewVale Capital backs companies at Early Stage, Growth and Late Stage, writing cheques of 10M - 50M.
Which regions does NewVale Capital invest in?
NewVale Capital invests across United States.
Who are the partners at NewVale Capital?
Team members listed for NewVale Capital include Todd Holmes (Founder and Managing Partner) and Andra Stene (Vice President, Finance and Operations).
What companies has NewVale Capital invested in?
NewVale Capital's portfolio includes Aizon, Argonaut Manufacturing Services and Beaconcure.
How do I contact NewVale Capital?
NewVale Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
